Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection.
作者信息
Fahey J L
机构信息
Departments of Medicine and of Microbiology and Immunology, Jonsson Comprehensive Cancer Center, Los Angeles, California 90095-1747, USA.
出版信息
Clin Diagn Lab Immunol. 1998 Sep;5(5):597-603. doi: 10.1128/CDLI.5.5.597-603.1998.
Abstract
摘要
相似文献
1
Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection.人类免疫缺陷病毒感染中的细胞因子、血浆免疫激活标志物及临床相关替代标志物
Clin Diagn Lab Immunol. 1998 Sep;5(5):597-603. doi: 10.1128/CDLI.5.5.597-603.1998.
2
Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures.人类免疫缺陷病毒感染患者血浆中细胞因子和免疫激活标志物水平：质量控制程序
Clin Diagn Lab Immunol. 1998 Nov;5(6):755-61. doi: 10.1128/CDLI.5.6.755-761.1998.
3
The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults.
J Infect Dis. 1998 Dec;178(6):1642-8. doi: 10.1086/314491.
4
Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease.对印度南部感染1型人类免疫缺陷病毒C亚型的受试者的病毒学和免疫学参数进行评估，并将研究结果与神经疾病的发生情况进行相关性分析。
J Neurovirol. 2009 Jan;15(1):25-35. doi: 10.1080/13550280802338652. Epub 2008 Nov 22.
5
Direct relationship between virus load and systemic immune activation in HIV-2 infection.HIV-2 感染中病毒载量与全身免疫激活之间的直接关系。
J Infect Dis. 2010 Jan 1;201(1):114-22. doi: 10.1086/648733.
6
Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.人类免疫缺陷病毒 1 型感染患者的 Epstein-Barr 病毒载量和免疫激活。
J Clin Virol. 2012 Mar;53(3):195-200. doi: 10.1016/j.jcv.2011.12.013. Epub 2011 Dec 30.
7
Relationship of plasma HIV-RNA levels and levels of TNF-alpha and immune activation products in HIV infection.HIV感染中血浆HIV-RNA水平与TNF-α水平及免疫激活产物之间的关系。
Clin Immunol Immunopathol. 1997 Jul;84(1):36-45. doi: 10.1006/clin.1997.4364.
8
Acute HIV-1 seroconversion with an unusual plasma biomarker profile.具有异常血浆生物标志物谱的急性HIV-1血清转化
Clin Vaccine Immunol. 2013 Nov;20(11):1774-7. doi: 10.1128/CVI.00366-13. Epub 2013 Sep 4.
9
Old and new plasma biomarkers in HIV-1-infected African-American women.
AIDS. 2011 Sep 24;25(15):1921-3. doi: 10.1097/QAD.0b013e32834a1e77.
10
During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.在丙型肝炎病毒（HCV）感染和HCV-HIV合并感染期间，自分泌运动因子血浆水平升高与溶血磷脂酸及免疫激活标志物相关，这些指标在无干扰素的HCV治疗期间恢复正常。
J Infect Dis. 2016 Nov 1;214(9):1438-1448. doi: 10.1093/infdis/jiw372. Epub 2016 Aug 17.
引用本文的文献
1
Using Laboratory Test Results for Surveillance During a New Outbreak of Acute Hepatitis in 3-Week- to 5-Year-Old Children in the United Kingdom, the Netherlands, Ireland, and Curaçao: Observational Cohort Study.在英国、荷兰、爱尔兰和库拉索岛3周龄至5岁儿童急性肝炎新疫情期间利用实验室检测结果进行监测：观察性队列研究。
JMIR Public Health Surveill. 2024 Dec 23;10:e55376. doi: 10.2196/55376.
2
Prevalence of Cytopenia and its Correlation with Immunosuppression in Naïve HIV-1 Infected Patients Initiating First-Line Antiretroviral Therapy: A Pilot Study.初治HIV-1感染患者开始一线抗逆转录病毒治疗时血细胞减少的患病率及其与免疫抑制的相关性：一项试点研究。
Infect Chemother. 2023 Dec;55(4):479-489. doi: 10.3947/ic.2023.0080.
3
Association of Fatty Acid Signatures with HIV Viremia in Pregnancy.脂肪酸特征与妊娠期间 HIV 病毒血症的关联。
AIDS Res Hum Retroviruses. 2024 Apr;40(4):257-267. doi: 10.1089/AID.2023.0040. Epub 2023 Oct 30.
4
A high-throughput screening RT-qPCR assay for quantifying surrogate markers of immunity from PBMCs.一种从 PBMCs 中定量免疫替代标志物的高通量筛选 RT-qPCR 检测方法。
Front Immunol. 2022 Aug 30;13:962220. doi: 10.3389/fimmu.2022.962220. eCollection 2022.
5
Evaluation of the Immunoprotective Potential of Recombinant Paraflagellar Rod Proteins of in Mice.重组鞭毛杆蛋白在小鼠中的免疫保护潜力评估。 （你提供的原文中“of”后面缺少具体内容，我按照完整语义补充翻译了，你可根据实际情况调整。）
Vaccines (Basel). 2020 Feb 12;8(1):84. doi: 10.3390/vaccines8010084.
6
Inflammation and Risk of Depression in HIV: Prospective Findings From the Multicenter AIDS Cohort Study.HIV 感染者炎症与抑郁风险：来自多中心艾滋病队列研究的前瞻性研究结果。
Am J Epidemiol. 2019 Nov 1;188(11):1994-2003. doi: 10.1093/aje/kwz190.
7
Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests.健康个体中免疫血液生物标志物的生物学变异及生物标志物检测的质量目标。
BMC Immunol. 2019 Sep 14;20(1):33. doi: 10.1186/s12865-019-0313-0.
8
Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy.表达组织因子的炎症单核细胞驱动 SIV 和 HIV 凝血障碍。
Sci Transl Med. 2017 Aug 30;9(405). doi: 10.1126/scitranslmed.aam5441.
9
Measurement of Circulating Cytokines and Immune-Activation Markers by Multiplex Technology in the Clinical Setting: What Are We Really Measuring?临床环境中采用多重技术检测循环细胞因子和免疫激活标志物：我们究竟在检测什么？
For Immunopathol Dis Therap. 2015;6(1-2):19-22. doi: 10.1615/ForumImmunDisTher.2015014162.
10
The Initial Months of Antiretroviral Therapy and Its Influence on AGEs, HMGB1, and sRAGE Levels in Asymptomatic HIV-Infected Individuals.无症状HIV感染者抗逆转录病毒治疗的最初几个月及其对晚期糖基化终末产物、高迁移率族蛋白B1和可溶性晚期糖基化终末产物受体水平的影响。
Mediators Inflamm. 2016;2016:2909576. doi: 10.1155/2016/2909576. Epub 2016 Nov 30.
本文引用的文献
1
The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes.由细胞表面抗原和血浆激活标志物变化所代表的免疫激活在HIV感染中的预后意义。
Clin Immunol. 1999 Feb;90(2):238-46. doi: 10.1006/clim.1998.4646.
2
Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements.免疫激活的血浆标志物、HIV病毒载量及CD4 T细胞检测的预后意义
AIDS. 1998 Sep 10;12(13):1581-90. doi: 10.1097/00002030-199813000-00004.
3
Host factors in the pathogenesis of HIV disease.HIV疾病发病机制中的宿主因素。
Immunol Rev. 1997 Oct;159:31-48. doi: 10.1111/j.1600-065x.1997.tb01005.x.
4
Inhibition of HIV-1 infection by the beta-chemokine MDC.β趋化因子MDC对HIV-1感染的抑制作用。
Science. 1997 Oct 24;278(5338):695-8. doi: 10.1126/science.278.5338.695.
5
A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.医护人员经皮暴露后HIV血清转化的病例对照研究。疾病控制与预防中心针刺伤监测小组。
N Engl J Med. 1997 Nov 20;337(21):1485-90. doi: 10.1056/NEJM199711203372101.
6
Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.在多中心艾滋病队列研究中，CD8+ T细胞上CD38抗原表达升高比CD4+细胞计数、可溶性免疫激活标志物或HLA-DR与CD38表达的组合，更能有力地预示慢性HIV疾病进展为艾滋病和死亡的风险。
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Oct 1;16(2):83-92. doi: 10.1097/00042560-199710010-00003.
7
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.原发性感染和长期非进展性感染中针对1型人类免疫缺陷病毒的中和抗体反应。
J Infect Dis. 1997 Oct;176(4):924-32. doi: 10.1086/516508.
8
Relationship of plasma HIV-RNA levels and levels of TNF-alpha and immune activation products in HIV infection.HIV感染中血浆HIV-RNA水平与TNF-α水平及免疫激活产物之间的关系。
Clin Immunol Immunopathol. 1997 Jul;84(1):36-45. doi: 10.1006/clin.1997.4364.
9
Circulating CD8 T cells show increased interferon-gamma mRNA expression in HIV infection.循环CD8 T细胞在HIV感染中显示出干扰素-γ mRNA表达增加。
Cell Immunol. 1997 May 25;178(1):91-8. doi: 10.1006/cimm.1997.1115.
10
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.血浆病毒载量和CD4 +淋巴细胞作为HIV-1感染的预后标志物。
Ann Intern Med. 1997 Jun 15;126(12):946-54. doi: 10.7326/0003-4819-126-12-199706150-00003.
Zotero 插件